EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Ultrashort vs Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI

Hendrianus Hendrianus, Diana A Gorog, Udaya S Tantry, Eliano P Navarese, Sang Yeub Lee, Jun Hwan Cho, Jinhwan Jo, Jeonghoon Bae, Sam Yeol Ha, Satoshi Honda, Satoshi Yasuda, Bambang Widyantoro und 4 weitere

JACC: Cardiovascular Interventions · 2026-09 · 19 (17) · 2311-2329

DOI: 10.1016/j.jcin.2026.07.012 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JACC: Cardiovascular Interventions, 2026-09. Verfasst von Hendrianus Hendrianus und 15 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Brain Hospital, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea; Department of Internal Medicine, Chung-Ang University …. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Acute Coronary Syndrome, Percutaneous Coronary Intervention, Dual Anti-Platelet Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Chung-Ang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The efficacy and safety of ultrashort (≤1-month) dual antiplatelet therapy (DAPT) followed by antiplatelet monotherapy remain uncertain in acute coronary syndrome (ACS) patients. OBJECTIVES: This study sought to compare ultrashort vs standard-duration DAPT in patients with ACS undergoing percutaneous coronary intervention (PCI). METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials until February 15, 2026. Primary outcomes were major adverse cardiac and cerebrovascular events (MACCE), major bleeding, and net adverse clinical event (NACE). Prespecified subgroup analyses examined by ethnicity (East Asian vs non-East Asian) and abbreviation strategy (intensive: ≤1-week DAPT or clopidogrel/aspirin monotherapy vs moderate: ≥2-week DAPT, followed by ticagrelor/prasugrel monotherapy). RESULTS: Across 10 trials (n = 29,232), ultrashort DAPT did not increase MACCE risk (HR: 1.06; 95% CI: 0.93-1.20; P = 0.38; I2 = 24%), with higher MACCE risk observed in ST-segment elevation myocardial infarction (STEMI) but not non-ST-segment elevation ACS (NSTE-ACS), and significantly reduced major bleeding (HR: 0.47; 95% CI: 0.35-0.64; P < 0.00001; I2 = 44%), resulting in a net clinical benefit (HR: 0.83; 95% CI: 0.72-0.97; P = 0.02; I2 = 61%). Bleeding reduction was more pronounced in East Asians (HR: 0.35; 95% CI: 0.25-0.49; P < 0.00001; I2 = 0%) than non-East Asians (HR: 0.63; 95% CI: 0.43-0.93; P = 0.02; I2 = 44%), with a significant interaction (P = 0.02). The abbreviation strategy significantly modified outcomes (P for interaction = 0.003): intensive abbreviation raised MACCE risk (HR: 1.37; 95% CI: 1.11-1.69; P = 0.003; I2 = 0%), while moderate abbreviation had no statistically significant difference (HR: 0.96; 95% CI: 0.85-1.08; P = 0.47; I2 = 0%). CONCLUSIONS: In patients with ACS undergoing PCI, ultrashort DAPT reduced bleeding without increasing ischemic events overall, although a signal of increased MACCE was observed in STEMI but not in NSTE-ACS. Bleeding reduction was greater in East Asians, while ≤1-week DAPT or clopidogrel/aspirin monotherapy may increase ischemic risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsAcute Coronary SyndromePercutaneous Coronary InterventionDual Anti-Platelet TherapyHumansTreatment OutcomeTime FactorsRisk FactorsHemorrhageRisk AssessmentDrug Administration ScheduleMaleAgedFemaleMiddle AgedRandomized Controlled Trials as TopicAspirinClopidogrel

Stichwörter der Autor:innen

East AsianP2Y(12) inhibitoracute coronary syndromedual antiplatelet therapymajor bleedingpercutaneous coronary intervention

Substanzen

Platelet Aggregation InhibitorsAspirinClopidogrel

Autor:innen und Institutionen

  • Heart and Brain Hospital, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea; Division of Cardiology, Natun…
  • Cardiovascular Division, Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Centre for Health Services and Clinical Research, Postgraduate Medical School, University…
  • Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital, Baltimore, Maryland, USA.
  • Department of Life and Health Sciences, Link Campus University, Rome, Italy; Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Heart and Brain Hospital, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, South Korea.
  • Department of Neurology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea.

Förderung

  • Chung-Ang University

Zitieren

APA

Hendrianus, H., Gorog, D. A., Tantry, U. S., Navarese, E. P., Lee, S. Y., Cho, J. H., Jo, J., Bae, J., Ha, S. Y., Honda, S., Yasuda, S., Widyantoro, B., Soerianata, S., Gurbel, P. A., Kim, S. W., & Jeong, Y. H. (2026). Ultrashort vs Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI. JACC: Cardiovascular Interventions, 19(17), 2311-2329. https://doi.org/10.1016/j.jcin.2026.07.012

Vancouver

Hendrianus H, Gorog DA, Tantry US, Navarese EP, Lee SY, Cho JH, et al. Ultrashort vs Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI. JACC: Cardiovascular Interventions. 2026;19(17):2311-2329. doi:10.1016/j.jcin.2026.07.012

BibTeX
@article{Hendrianus2026,
  author = {Hendrianus, Hendrianus and Gorog, Diana A and Tantry, Udaya S and Navarese, Eliano P and Lee, Sang Yeub and Cho, Jun Hwan and Jo, Jinhwan and Bae, Jeonghoon and Ha, Sam Yeol and Honda, Satoshi and Yasuda, Satoshi and Widyantoro, Bambang and Soerianata, Sunarya and Gurbel, Paul A and Kim, Sang-Wook and Jeong, Young-Hoon},
  title = {Ultrashort vs Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {17},
  pages = {2311--2329},
  doi = {10.1016/j.jcin.2026.07.012}
}
Kostenlos starten →